Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jamie A. Mullally"'
Publikováno v:
AACE Clinical Case Reports, Vol 10, Iss 5, Pp 170-173 (2024)
Background/Objective: Atypical femur fractures (AFFs) caused by long-term bisphosphonate use are associated with high rates of delayed healing and nonunion. Case Report: A 64-year-old woman with osteopenia on alendronate for 15 years sustained a disp
Externí odkaz:
https://doaj.org/article/bc60e5e1a390404f91c7147bb8199222
Autor:
Yusra Jamal, Yudi Camacho, Simon Hanft, Patrick Chiarolanzio, Michael D. Goldberg, Jamie A. Mullally
Publikováno v:
Case Reports in Endocrinology, Vol 2023 (2023)
Background. Pituitary apoplexy (PA) is a clinical syndrome of pituitary hemorrhage or infarction and can result in hypopituitarism as well as compression of adjacent brain structures. Visual loss occurs frequently, as a result of tumor expansion and
Externí odkaz:
https://doaj.org/article/7b9c537a045f4a039c12855429de2378
Autor:
Dennis C. Boyle, Jamie A. Mullally
Publikováno v:
Case Reports in Endocrinology, Vol 2023 (2023)
Background and Objective. Mounting evidence implicates COVID-19 as a cause of thyroid dysfunction, including thyrotoxicosis due to both thyroiditis and Graves’ disease (GD). In this report, we present a case of thyrotoxicosis following COVID-19 inf
Externí odkaz:
https://doaj.org/article/cbe452eea9244bc6ab43d58409bd9b3b
Publikováno v:
Cardiology in Review.
Autor:
Jamie A. Mullally, Rajasekhar Ramakrishnan, Steven Holleran, Tirissa J. Reid, Charles A. LeDuc, Gerardo Febres, Wendy K. Chung, Judith Korner
Publikováno v:
Diabetes, Obesity and Metabolism. 23:850-853
Naltrexone/bupropion (NB) is a US Food and Drug Administration-approved antiobesity medication. Clinical trials have shown variable weight loss, with responders and non-responders. NB is believed to act on central dopaminergic pathways to suppress ap
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Scientific Reports
Scientific Reports
Bariatric surgery is a treatment option for obese patients with type 2 diabetes mellitus (T2DM). Although sleeve gastrectomy (SG) is growing in favor, some randomized trials show less weight loss and HbA1c improvement compared with Roux-en-Y gastric
Autor:
Jamie A, Mullally, Wendy K, Chung, Charles A, LeDuc, Tirissa J, Reid, Gerardo, Febres, Steven, Holleran, Rajasekhar, Ramakrishnan, Judith, Korner
Publikováno v:
Diabetes Obes Metab
Naltrexone/bupropion (NB) is a US Food and Drug Administration-approved antiobesity medication. Clinical trials have shown variable weight loss, with responders and non-responders. NB is believed to act on central dopaminergic pathways to suppress ap
Publikováno v:
Blood. 138:4540-4540
Brentuximab is a CD-30-directed antibody-drug conjugate. The addition of brentuximab vedotin (BV) to adriamycin, vinblastine, and dacarbazine (AVD) has become a standard-of-care approach for advanced stage Hodgkin Lymphoma. BV has well known toxiciti
Publikováno v:
Endocrine Practice. 27:S111
Autor:
Tanvisha Mody, Jamie A. Mullally
Publikováno v:
Journal of the Endocrine Society. 5:A216-A216
Introduction: Rhabdomyolysis is characterized by elevated creatine kinase, electrolyte abnormalities and acute renal failure. After the initial hypocalcemic phase, serum calcium levels can normalize or become significantly elevated during the recover